Per ulteriori informazioni selezionare i riferimenti di interesse.
Long-term administration of docosahexaenoic acid attenuated biogenic aminelevels in stroke-prone spontaneously hypertensive rats
BIOGENIC AMINES
Nitric oxide and neuronal and pancreatic beta cell death
TOXICOLOGY
Cell death induced by MPTP, a substrate for monoamine oxidase B
TOXICOLOGY
Neurochemistry and neuropharmacology of emesis - the role of serotonin
TOXICOLOGY
MPTP neurotoxins inducing cell death and a substrate for B form of enzyme monoamine oxidase
BIOGENIC AMINES
Intracellular regulatory mechanisms of 5-HT release from enterochromaffin cells in intestinal mucosa
BIOGENIC AMINES
Pancreatic beta cell death - is nitric oxide the culprit?
BIOGENIC AMINES
New advances in pathogenesis of stroke and vascular dementia in stroke-prone spontaneously hypertensive rats.
BIOGENIC AMINES
Ontogeny of monoamine oxidase A and B activities in developing chick cerebellum: a biochemical study
BIOGENIC AMINES
Methods for assaying monoamine oxidase A and B activities: recent developments.
BIOGENIC AMINES
Effect of isatin, an endogenous MAO inhibitor, on acetylcholine and dopamine levels in the rat striatum.
BIOGENIC AMINES
THE NEUROCHEMICAL MARKERS IN CEREBROSPINAL-FLUID TO DIFFERENTIATE BETWEEN ASEPTIC AND TUBERCULOUS MENINGITIS
Neurochemistry international
ASSOCIATION STUDY OF MUTATION G(-75)-]A IN THE PROMOTER OF THE HUMAN APOLIPOPROTEIN AI GENE AND ESSENTIAL-HYPERTENSION
Biogenic amines
CHOLECYSTOKININS AND THEIR COEXISTENCE WITH CATECHOLAMINES IN CEREBROSPINAL-FLUID OF PATIENTS WITH SOME NEUROLOGICAL DISORDERS
Biogenic amines
METHYLCOBALMINE (V-B-12) INCREASES CEREBRAL ACETYLCHOLINE LEVELS AND IMPROVES PASSIVE-AVOIDANCE RESPONSE IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
Biogenic amines
Neuropeptide Y, noradrenaline and their existence in cerebrospinal fluid of patients with ischemic brain stroke
BIOGENIC AMINES
URINARY 5-HIAA EXCRETION IN RATS AFTER CHRONIC ADMINISTRATION OF CYCLOPHOSPHAMIDE
Biogenic amines
BASAL AND SEROTONIN OR FORSKOLIN-STIMULATED SARCOLEMMAL ADENYLYL-CYCLASE ACTIVITY IN THE SKELETAL MUSCULATURE OF THE INTACT AND ONTOGENETICALLY SEROTONIN-FREE MALE-RAT - QUANTITATIVE DIFFERENCES IN ENZYME-ACTIVITY BETWEEN PERINEAL AND OTHER SKELETAL-MUSCLES
Biogenic amines
IMMUNOHISTOCHEMICAL LOCALIZATION OF VIMENTIN, S-100 PROTEIN AND NEUROFILAMENT IN THE LACRIMAL GLAND OF THE CAMEL (CAMELUS-DROMEDARIUS)
Biogenic amines
BIOCHEMICAL MARKERS IN TUBERCULOSIS MENINGITIS
Biogenic amines
SIGNIFICANCE OF ISATIN, AN ENDOGENOUS MAO INHIBITOR, ON BLOOD-PRESSURE CONTROL AND MONOAMINE LEVELS IN RATS
Biogenic amines
REEVALUATION OF SYRIAN-HAMSTER BIO14.6 AS A MODEL ANIMAL FOR CONGESTIVE-HEART-FAILURE AND CATECHOLAMINE TURNOVER
Biogenic amines
CHANGES IN THE AFFERENT ABDOMINAL VAGAL NERVE ACTIVITY-INDUCED BY CISPLATIN AND COPPER-SULFATE IN THE FERRET
Biogenic amines
INHIBITION OF RAT-BRAIN MONOAMINE-OXIDASE BY INDOLE-2, 3-DIONE (ISATIN) AND ITS STRUCTURAL ANALOGS
Biogenic amines
IDENTIFICATION OF ISATIN, AN ENDOGENOUS MAO INHIBITOR, IN THE BRAIN OF STROKE-PRONE SHR
Biogenic amines
SALSOLINOLS AND OTHER 6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINES AS INHIBITORS OF MONOAMINE-OXIDASE - IN-VIVO AND IN-VITRO STUDY
Biogenic amines
EFFECTS OF ANTICANCER DRUGS ON ENZYME-ACTIVITIES AND SEROTONIN RELEASE FROM ILEAL TISSUE IN FERRETS
Biogenic amines